NEBA Health has secured FDA approval for its Neuropsychiatric EEG-Based Assessment Aid System. The test uses brain waves to help identify the presence of attention-deficit/hyperactivity disorder in children younger than 18.
FDA approves first brain-wave device for ADHD detection
SmartBrief Job Listings for Health Care
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||